Effect of weekly versus daily primaquine on Plasmodium vivax malaria recurrences: A real-life cohort study.
Rev Soc Bras Med Trop
; 55: e07382021, 2022.
Article
em En
| MEDLINE
| ID: mdl-35522815
ABSTRACT
BACKGROUND:
Although primaquine (PQ) is indicated for G6PD-deficient patients, data on weekly PQ use in Brazil are limited.METHODS:
We aimed to investigate malaria recurrences among participants receiving daily and weekly PQ treatments in a real-life setting of two municipalities in the Amazon between 2019 and 2020.RESULTS:
Patients receiving weekly PQ treatment had a lower risk of recurrence than those receiving daily PQ treatment (risk ratio 0.62, 95% confidence interval 0.41-0.94), using a model adjusted for study site.CONCLUSIONS:
Weekly PQ use did not increase the risk of malaria recurrence. Further studies with larger populations are warranted.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Malária Vivax
/
Antimaláricos
Idioma:
En
Ano de publicação:
2022
Tipo de documento:
Article